GlassScriptPhysician profile
Mahsa Madani
NPI 1245791243
$837.64
in general payments reported to CMS, 2019-2025
19 companies · $383 in 2025
The $383 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $87.42 · 2024: $368 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $837.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $165.59 | 2024-2025 | |
| Gilead Sciences, INC. | $87.23 | 2025 | |
| Abiomed | $81.02 | 2023-2024 | Impella |
| Exact Sciences Corporation | $59.26 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $56.09 | 2024-2025 | Airsupra |
| Sanofi-Aventis U.S. LLC | $43.36 | 2025 | |
| Glaxosmithkline, LLC. | $42.37 | 2023-2025 | Arexvy, Shingrix |
| Phadia US INC. | $39.90 | 2024 | Immunocap |
| Almatica Pharma LLC | $35.80 | 2024-2025 | Loreev Xr |
| Alexion Pharmaceuticals, INC. | $31.34 | 2025 | Ultomiris |
| Agios Pharmaceuticals, INC. | $25.94 | 2024 | |
| Lilly USA, LLC | $25.57 | 2023 | Mounjaro, Trulicity |
| Viiv Healthcare Company | $25.34 | 2024 | Apretude |
| Merck Sharp & Dohme LLC | $23.67 | 2024 | Gardasil, Capvaxive, Gardasil 9 |
| Novo Nordisk INC | $22.93 | 2024 | Rybelsus, Ozempic |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $22.14 | 2024 | Xarelto |
| Kowa Pharmaceuticals America, INC. | $18.14 | 2025 | Zoryve |
| Abbott Laboratories | $17.57 | 2025 | Eterna |
| Bayer Healthcare Pharmaceuticals INC. | $14.38 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahsa Madani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.